NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
05/03/2022
Back to search
Official data from USPTO
PHARMICS INC.
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
05/03/2022
Trademark type
Combined
Nice classes
5, 18, 35, 101
Filing date
04/06/1970
Registration date
10/24/1972
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/03/2022
Last transaction
05/03/2022
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
03/24/1970
First use in commerce
03/24/1970
Drawing code
5
Owner type
03
Owner location
Salt Lake, UT, US
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
PHARMICS, INC.
Representatives
LYNN G. FOSTER
Technical classification
Nice Classes
Class 5Class 18Class 35Class 101
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
No specification.
Class 18
FOOD SUPPLEMENTSVITAMINS AND PHARMACEUTICALS COMPRISING ANTI-HISTAMINE DECONGESTANTSANTI-TUSSIVESEXPECTORANT ANALGESICSCOUGH MEDICINES
Class 35
No specification.
Class 101
DISTRIBUTORSHIP SERVICE IN THE FIELD OF PHARMACEUTICALS
Publications
History of USPTO decisions and trademark events.
27 publications found
RNL4
REGISTERED AND RENEWED (FOURTH RENEWAL - 10 YRS)
05/03/2022
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
05/03/2022
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
04/29/2022
PR89
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
04/07/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/07/2022
E89R
TEAS SECTION 8 & 9 RECEIVED
12/09/2021
RNL3
REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS)
01/10/2012
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
01/10/2012
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/10/2012
89AF
REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
12/06/2011
PAPER RECEIVED
12/06/2011
CORV
REVIEW OF CORRESPONDENCE COMPLETE
09/18/2009
CORV
REVIEW OF CORRESPONDENCE COMPLETE
09/17/2009
PAPER RECEIVED
08/24/2009
CFIT
CASE FILE IN TICRS
08/29/2008
CORV
REVIEW OF CORRESPONDENCE COMPLETE
02/07/2008
PAPER RECEIVED
01/25/2008
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
07/11/2002
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
07/11/2002
89AF
REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
05/06/2002
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
10/13/1992
RRPR
RESPONSE RECEIVED TO POST REG. ACTION
09/11/1992
9.AF
REGISTERED - SEC. 9 FILED/CHECK RECORD FOR SEC. 8
09/11/1992
PRA9
POST REGISTRATION ACTION MAILED - SEC. 9
08/17/1992
9.AF
REGISTERED - SEC. 9 FILED/CHECK RECORD FOR SEC. 8
05/20/1992
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
02/27/1979
Continuous trademark protection
Get notified about every new filing that threatens PHARMICS INC. or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.